Novartis: 58 billion dollars of sales in 2013
Novartis has announced its full-year financial results, included sales of $58 billion, up 4% on the previous year but “narrowly missing” predictions according to The Wall Street Journal.
Joseph Jimenez, the company’s chief executive, is reportedly looking to potential joint ventures as part of a strategy to explore “unique structures”.
“We maintained good momentum in innovation, with 18 approvals and three FDA breakthrough therapy designations.
“Our growth products continued to expand, rejuvenating our portfolio and reinforcing our growth prospects.”
Joseph Jimenez, chief executive, Novartis.
Novartis earnings miss forecasts (The Wall Street Journal)
Annual results (Novartis).
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.